Famotidine
Rank #183 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$84.3M
Total Cost
5,257,365
Total Claims
$84.3M
Total Cost
91,359
Prescribers
$16
Cost per Claim
1,394,949
Beneficiaries
10,024,157
30-Day Fills
$923
Avg Cost/Provider
58
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$84.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $84.3M total
🔎 Data Overview
At $16.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Famotidine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Hossam Amin | Pulmonary Disease | Brooklyn, NY | 2,083 | $475K |
| 2 | Amr Nayel | Family Practice | Astoria, NY | 308 | $116K |
| 3 | Tigalat Shalita | Family Practice | West Hills, CA | 227 | $55K |
| 4 | Andrew Avery | Internal Medicine | Detroit, MI | 240 | $50K |
| 5 | Daniel Megna | Gastroenterology | Staten Island, NY | 2,122 | $49K |
| 6 | Ricky Lockett | Physical Medicine and Rehabilitation | Saint Petersburg, FL | 100 | $47K |
| 7 | Claudia Pineda-Muyir | Physician Assistant | Brooklyn, NY | 270 | $45K |
| 8 | Sergio Martinez | Pulmonary Disease | Jackson Heights, NY | 232 | $45K |
| 9 | Michael Satchell | Family Practice | Albany, GA | 6,635 | $44K |
| 10 | Bob Souder | Gastroenterology | Jackson, TN | 1,434 | $42K |
| 11 | Laila Farhat | Internal Medicine | Brooklyn, NY | 208 | $41K |
| 12 | Angel Ayala Morales | General Practice | Ponce, PR | 3,620 | $39K |
| 13 | Rita Goldvug | Internal Medicine | Rego Park, NY | 24 | $38K |
| 14 | Kyi Yu | Family Practice | Rockaway Beach, NY | 342 | $37K |
| 15 | Luis Rodriguez-Saenz | Family Practice | Cayey, PR | 3,007 | $34K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 180 | Galcanezumab-Gnlm (Emgality Pen) | $87.0M | 101,221 |
| 181 | Imatinib Mesylate (Imatinib Mesylate) | $85.0M | 40,908 |
| 182 | Clopidogrel Bisulfate (Clopidogrel) | $84.7M | 5,428,304 |
| 183 | Famotidine (Famotidine) | $84.3M | 5,257,365 |
| 184 | Mifepristone (Korlym) | $83.3M | 2,397 |
| 185 | Insulin Nph Hum/Reg Insulin Hm (Humulin 70-30) | $82.3M | 177,501 |
| 186 | Montelukast Sodium (Montelukast Sodium) | $81.3M | 5,086,706 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology